Ontario Teachers Pension Plan Board Amgen Inc Transaction History

Ontario Teachers Pension Plan Board

$11.6 Billion
Q3 2024

A detailed history of Ontario Teachers Pension Plan Board transactions in Amgen Inc stock. As of the latest transaction made, Ontario Teachers Pension Plan Board holds 2,786 shares of AMGN stock, worth $822,037. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,786

Previous 9,874 71.78%

Holding current value

$822,037

Previous $3.09 Million 70.92%

% of portfolio

0.01%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $2.19 Million - $2.39 Million	-7,088 Reduced 71.78%	2,786 $897,000
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $97,217 - $118,144	370 Added 3.89%	9,874 $3.09 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $1.4 Million - $1.69 Million	-5,199 Reduced 35.36%	9,504 $2.7 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $275,133 - $310,382	-1,076 Reduced 6.82%	14,703 $4.23 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $431,396 - $535,590	1,973 Added 14.29%	15,779 $4.24 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $2.96 Million - $3.5 Million	13,806 New	13,806 $3.07 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $1.07 Million - $1.3 Million	4,725 Added 32.7%	19,176 $4.64 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $193,988 - $246,485	847 Added 6.23%	14,451 $3.8 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $1.27 Million - $1.43 Million	5,655 Added 71.14%	13,604 $3.07 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $799,640 - $889,860	3,466 Added 77.31%	7,949 $1.93 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $26,093 - $28,865	-119 Reduced 2.59%	4,483 $1.08 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $190,725 - $218,268	-959 Reduced 17.25%	4,602 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $369,137 - $432,489	1,739 Added 45.5%	5,561 $1.18 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $45,548 - $50,532	-195 Reduced 4.85%	3,822 $932,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $76,558 - $89,217	-345 Reduced 7.91%	4,017 $999,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $750,189 - $893,341	-3,467 Reduced 44.28%	4,362 $1 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $518,107 - $576,177	-2,208 Reduced 22.0%	7,829 $1.99 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $995,775 - $1.22 Million	5,034 Added 100.62%	10,037 $2.37 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $1.65 Million - $2.19 Million	-9,062 Reduced 64.43%	5,003 $1.01 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $648,611 - $833,689	-3,428 Reduced 19.6%	14,065 $3.39 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $5.62 Million - $6.73 Million	-32,252 Reduced 64.83%	17,493 $3.39 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $5.15 Million - $6.03 Million	30,865 Added 163.48%	49,745 $9.17 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $4.41 Million - $4.97 Million	-24,401 Reduced 56.38%	18,880 $3.59 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $7.72 Million - $9.01 Million	43,281 New	43,281 $8.43 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $1.26 Million - $1.42 Million	-6,803 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $1.13 Million - $1.27 Million	6,803 New	6,803 $1.26 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $16.4 Million - $19.1 Million	-96,697 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $4.19 Million - $4.69 Million	24,851 Added 34.59%	96,697 $16.8 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $12 Million - $13.7 Million	71,846	71,846 $13.4 Million

Others Institutions Holding AMGN

# of Institutions

3,118

Shares Held

410M

Call Options Held

8.54M

Put Options Held

7.02M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.

Account

Ontario Teachers Pension Plan Board Amgen Inc Transaction History